In the everyday life of many people living with HIV, the virus today often plays a noticeably smaller role than it did in the past, because modern therapies enable a long life with a high quality of life. Precisely for this reason, it can sometimes feel as if there is no longer a need to engage with it intensely. Yet looking more closely reveals this: Current knowledge about HIV remains important — because medicine is advancing, new therapy options are becoming available, and life itself can change.
Information about HIV is now widely available: on websites, in social media, and increasingly also through Artificial Intelligence (AI). All the more important is the question: Which sources can I truly trust?
Why good information can make a difference
When you’re well informed, you gain confidence. This applies to fundamentals like U=U — that people with HIV on effective therapy and with an undetectable viral load cannot sexually transmit HIV.1,2
Equally important is looking forward: What new developments exist? Which therapy options are available today? And which of those might fit your life better than the current therapy? Being well informed isn’t just about “knowing.” It also means being able to continually reframe your own situation as life evolves.
Why up-to-date information matters for your own therapy
Many people living with HIV know this feeling: the therapy is working, daily life is running smoothly, and the topic gradually moves into the background. That is a good thing. At the same time, it can lead to not checking whether the current therapy still fits your life as well as it did before.
Life circumstances change, and sometimes you only realize after a long time that something that “works” may no longer feel truly right. That’s precisely why it can be sensible to take a fresh look from time to time.
Today there are, for example, different therapy options and delivery formats. While some people manage a daily tablet well, others may find a therapy with a long-acting injectable better suited to their life. The key is to know the possibilities so you can review them together with your clinician.
Verlässliche Informationsquellen finden
When it comes to HIV, a specialized HIV-focused clinic is usually the most important starting point. At the same time, many questions often arise after an appointment — or there isn’t enough time to cover everything during the visit.
Therefore, additional, reliable information sources are helpful:
● Offerings from the German AIDS Help and local AIDS support services
● Digital HIV information resources such as www.LiVLife.de
● Formats for sharing personal experiences as well as peer support
And what about AI?
Today many people also turn to AI as a source of information. That’s understandable: answers come quickly, they’re presented clearly, and they’re available at any time. For this reason, AI can seem very helpful at first glance.
Important, though, is to know its limits. AI can summarize information, structure questions, and provide initial orientation. It can also contain errors, oversimplifications, or outdated statements — and it isn’t always obvious which sources the answer relies on. Especially with health topics, you should proceed with caution and view AI as an aid — not as the sole basis for medical decisions.
Being well informed means you can participate in decisions more effectively
Reliable information helps not only understanding but also participation in decisions. Those who are well informed can engage in conversations with clinicians on an equal footing and decide together.
A recent European survey also shows that many people do not regularly discuss new therapy options with their treating practice — and some report never having such conversations.3
A good next step may be to, at your next appointment, deliberately ask which information sources you consider reliable and which therapy options are available today.
For more information about living with HIV and personal stories from people with HIV, visit www.livlife.de
Supported by ViiV Healthcare
NP-DE-HVU-ADVR-260015
1 Eisinger et al., JAMA February 5, 2019 Volume 321, Number 5 (Reprinted).
2 European AIDS Clinical Society (EACS) Guidelines, Version 13.0, as of October 2025.
3 Devonald M et al., 20th European AIDS Conference (EACS) 2025. Poster MeP09.5.LB.